Version 5.4
Homo sapiens Protein: CHD3
Summary
InnateDB Protein IDBP-366902.4
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol CHD3
Protein Name chromodomain helicase DNA binding protein 3
Synonyms Mi-2a; Mi2-ALPHA; ZFH;
Species Homo sapiens
Ensembl Protein ENSP00000411959
InnateDB Gene IDBG-27053 (CHD3)
Protein Structure
UniProt Annotation
Function
Subcellular Localization
Disease Associations
Tissue Specificity
Comments
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 190 experimentally validated interaction(s) in this database.
They are also associated with 3 interaction(s) predicted by orthology.
Experimentally validated
Total 190 [view]
Protein-Protein 189 [view]
Protein-DNA 1 [view]
Protein-RNA 0
DNA-DNA 0
RNA-RNA 0
DNA-RNA 0
Predicted by orthology
Total 3 [view]
Gene Ontology

Molecular Function
Accession GO Term
GO:0003677 DNA binding
GO:0005524 ATP binding
GO:0008270 zinc ion binding
GO:0016818 hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides
Biological Process
GO:0006325 chromatin organization
GO:0006355 regulation of transcription, DNA-templated
GO:0007051 spindle organization
GO:0008152 metabolic process
GO:0051297 centrosome organization
Cellular Component
GO:0005634 nucleus
GO:0016581 NuRD complex
Protein Structure and Domains
PDB ID
InterPro IPR012957 CHD, C-terminal 2
PFAM PF08074
PRINTS
PIRSF
SMART
TIGRFAMs
Post-translational Modifications
Modification
Cross-References
SwissProt
PhosphoSite PhosphoSite-
TrEMBL H7C3H7
UniProt Splice Variant
Entrez Gene 1107
UniGene Hs.706339
RefSeq
HUGO HGNC:1918
OMIM 602120
CCDS
HPRD 09071
IMGT
EMBL AC104581
GenPept

If you use InnateDB for your research, please cite the following publication:

Breuer et al., InnateDB: systems biology of innate immunity and beyond - recent updates and continuing curation. Nucl. Acids Res. (2013) 41 (D1) 

InnateDB is being developed jointly by the Brinkman Laboratory (Simon Fraser University, British Columbia, Canada), the Hancock Laboratory (University of British Columbia, Vancouver, British Columbia) and the Lynn EMBL Australia Group (South Australian Health & Medical Research Institute and Flinders University, Adelaide, Australia).

Funding is currently provided by Allergen and EMBL Australia. Previous funding has been provided by Genome Canada, the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative and by Teagasc. InnateDB curated interactions are licensed under the Design Science License. All other data is licensed under the terms of the originating database. Contact: innatedb-mail@sfu.ca